La Asociación Española de Laboratorios de Medicamentos Huérfanos y Ultrahuérfanos (AELMHU) ha presentado sus comentarios al Procedimiento de Legislación Colaborativa del Plan Estratégico de Medicina Personalizada de Precisión de Castilla y León 2024-2030. La Asociación ... Leer más
07-11-2024
AELMHU 2024 awards ceremony
The Spanish Association of Orphan and Ultraphan Drug Laboratories has presented the awards of the sixth edition of the AELMHU Awards, in an emotional evening full of recognition, in which the most outstanding ... Read more
10-10-2024
Second Quarterly Access Report 2024
The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has published its Report on Access to Orphan Drugs in Spain for the second quarter of 2024. This publication, which analyzes the situation up to ... Read more
30-09-2024
Jury's decision for the AELMHU 2024 Awards
The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has published the jury's decision in the VI Edition of its Awards, aimed at recognizing the most significant contributions in the field of orphan and ultra orphan drugs.... Read more
29-07-2024
Comentarios a la Consulta Pública de Aragón
La Asociación Española de Laboratorios de Medicamentos Huérfanos y Ultrahuérfanos (AELMHU) ha presentado sus comentarios a la modificación de la orden del 13 de julio de 2007 del Departamento de Salud y Consumo por la ... Leer más
24-07-2024
AELMHU and the Consejo General de Colegios Farmacéuticos (General Council of Pharmaceutical Associations)
The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has held a meeting with the General Council of Official Pharmaceutical Associations (CGCOF), with the aim of strengthening the collaboration between both entities and ... Read more
